First orphan drug for hereditary factor X deficiency:coagadex
ZHAO Xiao-juan
ZHOU Li-ming
ZHAO Yong-hong
Abstract：Hereditary factor X deficiency is a rare bleeding disorder caused by a lack of clotting factor X in the blood.Coagadex is a plasma-derived blood coagulation factor X concentrate used to treat patients older than 12 years with mild hereditary factor X deficiency for the control of bleeding episodes and perioperative management of bleeding.The approval of coagadex is a significant advancement for patients who suffer from this rare but serious disease.Coagadex was safe and effective for the patients with hereditary factor X deficiency in clinical trials.
Keywords：coagulation disordercoagulation factor X deficiencycoagadexorphan drug
Publication Date：2016-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)